These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 37465376)
21. Lenalidomide treatment for recurrent adult T-cell leukemia/lymphoma after allogeneic hematopoietic cell transplantation. Tanaka T; Inamoto Y; Ito A; Watanabe M; Takeda W; Aoki J; Kim SW; Fukuda T Hematol Oncol; 2023 Aug; 41(3):389-395. PubMed ID: 36513602 [TBL] [Abstract][Full Text] [Related]
22. The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation. Kawano N; Yoshida S; Kawano S; Kuriyama T; Tahara Y; Toyofuku A; Manabe T; Doi A; Terasaka S; Yamashita K; Ueda Y; Ochiai H; Marutsuka K; Yamano Y; Shimoda K; Kikuchi I J Clin Exp Hematop; 2018 Sep; 58(3):107-121. PubMed ID: 30089749 [TBL] [Abstract][Full Text] [Related]
23. Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation. Trotta GE; Ciangola G; Cerroni I; Mezzanotte V; Nunzi A; Anemona L; Savino L; De Angelis G; Mariotti B; Bonanni F; Meddi E; Zizzari A; Rapisarda VM; Mangione I; Bruno A; Cantonetti M; Venditti A; Cerretti R Curr Res Transl Med; 2024 Sep; 72(3):103452. PubMed ID: 38718540 [TBL] [Abstract][Full Text] [Related]
24. Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia. Tanaka H; Fujiwara H; Ochi F; Tanimoto K; Casey N; Okamoto S; Mineno J; Kuzushima K; Shiku H; Sugiyama T; Barrett AJ; Yasukawa M Clin Cancer Res; 2016 Sep; 22(17):4405-16. PubMed ID: 27091408 [TBL] [Abstract][Full Text] [Related]
25. Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation. Morishige S; Nishi M; Saruta H; Arakawa F; Yamasaki Y; Oya S; Nakamura T; Seki R; Yamaguchi M; Aoyama K; Mouri F; Osaki K; Ohshima K; Nagafuji K Int J Hematol; 2019 Oct; 110(4):506-511. PubMed ID: 31152415 [TBL] [Abstract][Full Text] [Related]
26. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience. Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158 [TBL] [Abstract][Full Text] [Related]
27. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy. Sakamoto H; Itonaga H; Sawayama Y; Kojima A; Chiwata M; Fujioka M; Kitanosono H; Horai M; Miyazaki T; Shiraishi H; Imaizumi Y; Yoshida S; Hata T; Yamano Y; Miyazaki Y Int J Hematol; 2021 May; 113(5):765-769. PubMed ID: 33423163 [TBL] [Abstract][Full Text] [Related]
28. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia. Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P Front Immunol; 2021; 12():605766. PubMed ID: 34025637 [TBL] [Abstract][Full Text] [Related]
29. Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma. Ureshino H; Kusaba K; Kidoguchi K; Sano H; Nishioka A; Itamura H; Yoshimura M; Yokoo M; Shindo T; Kubota Y; Ando T; Kojima K; Sueoka E; Kimura S Ann Hematol; 2019 Feb; 98(2):465-471. PubMed ID: 30264165 [TBL] [Abstract][Full Text] [Related]
30. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation. Tamai Y; Hasegawa A; Takamori A; Sasada A; Tanosaki R; Choi I; Utsunomiya A; Maeda Y; Yamano Y; Eto T; Koh KR; Nakamae H; Suehiro Y; Kato K; Takemoto S; Okamura J; Uike N; Kannagi M J Immunol; 2013 Apr; 190(8):4382-92. PubMed ID: 23475215 [TBL] [Abstract][Full Text] [Related]
31. Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma. Winsett FT; Lewis DJ; Duvic M Expert Rev Hematol; 2017 Sep; 10(9):757-760. PubMed ID: 28756726 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma. Tsukasaki K; Marçais A; Nasr R; Kato K; Fukuda T; Hermine O; Bazarbachi A Front Microbiol; 2020; 11():1207. PubMed ID: 32636814 [TBL] [Abstract][Full Text] [Related]
34. [Successful umbilical cord blood hematopoietic stem cell transplantation in a patient with adult T-cell leukemia/lymphoma initially achieving complete remission with anti-CC chemokine receptor 4 antibody combined chemotherapy]. Suwabe T; Shibasaki Y; Kaihatsu A; Katagiri T; Miyakoshi S; Fuse K; Kobayashi H; Ushiki T; Moriyama M; Takizawa J; Narita M; Sone H; Masuko M Rinsho Ketsueki; 2017; 58(1):32-36. PubMed ID: 28190863 [TBL] [Abstract][Full Text] [Related]
35. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation. Tanaka Y; Nakasone H; Yamazaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Sato M; Terasako K; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y J Clin Immunol; 2012 Dec; 32(6):1340-52. PubMed ID: 22763862 [TBL] [Abstract][Full Text] [Related]
36. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect. Shiratori S; Yasumoto A; Tanaka J; Shigematsu A; Yamamoto S; Nishio M; Hashino S; Morita R; Takahata M; Onozawa M; Kahata K; Kondo T; Ota S; Wakasa K; Sugita J; Koike T; Asaka M; Kasai M; Imamura M Biol Blood Marrow Transplant; 2008 Jul; 14(7):817-23. PubMed ID: 18541202 [TBL] [Abstract][Full Text] [Related]
37. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma. Tanaka Y; Nakasone H; Yamazaki R; Sato K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Oshima K; Tanihara A; Nishida J; Yoshikawa T; Nakatsura T; Sugiyama H; Kanda Y Cancer Res; 2010 Aug; 70(15):6181-92. PubMed ID: 20647322 [TBL] [Abstract][Full Text] [Related]
38. [Treatment approach for relapse of adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation]. Kato K Rinsho Ketsueki; 2021; 62(5):505-511. PubMed ID: 34248128 [TBL] [Abstract][Full Text] [Related]
39. Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma. Ureshino H; Kamachi K; Kimura S Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):326-331. PubMed ID: 30981611 [TBL] [Abstract][Full Text] [Related]
40. Chemotherapy and allo-HSCT for young patients with aggressive ATL. Fuji S Leuk Res; 2024 Dec; 147():107596. PubMed ID: 39366195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]